Americans have been hearing a lot about peptide therapy, and, at Hims & Hers, we believe everyone deserves a responsible pathway to the latest innovations in longevity and wellness. The FDA’s plans to more clearly define the regulatory status of several peptides is an important step toward moving these treatments out of the gray market, and into more trusted channels overseen by vetted healthcare professionals.
As a physician, I know firsthand that people need clear information, thoughtful guidance, and care they can trust when exploring emerging treatments. Our medical team believes certain peptide therapies hold meaningful potential in helping Americans live healthier lives, and we are actively exploring how to expand access in a way that will be aligned with FDA guidance and reflects our commitment to consumer safety, transparency, and clinical excellence.
We believe strongly in a comprehensive standard of longevity care that spans new treatments, labs, and hormonal health. We will continue to work to set a standard in this emerging space that Americans can trust as they build their health and wellness.
